Effect of ZnO nanoparticles on ESBL producing Escherichia coli & Klebsiella spp

Eastern Journal of Medicine

Volumn 16, Issue 4, 2011, Pages 253-257

  Mustafa, Shoeb ^a   Khan, Haris M ^a   Shukla, Indu ^a   Shujatullah, Fatima ^a   Shahid, Mohd ^a   Ashfaq, Mohammad ^a   Azam, Ameer ^b  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Extended spectrum lactamase (ESBL); Klebsiella; Nanoparticle

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE; NANOPARTICLE; ZINC OXIDE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM ISOLATE; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ESCHERICHIA COLI INFECTION; GROWTH INHIBITION; KLEBSIELLA INFECTION; NONHUMAN; SPECTROPHOTOMETRY;

EID: 84865820122     PISSN: 13010883     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Jones N, Ray B, Ranjit KT, Manna AC. Antibacterial activity of ZnO nanoparticle suspensions on a broad spectrum of microorganisms. FEMS Microbiol Lett 2008; 279: 71-76.
2. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001; 14: 933-951.
3. Furno F, Morley KS, Wong B, et al. Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? J Antimicrob Chemother 2004; 54: 1019-1024.
4. Turos E, Reddy GS, Greenhalgh K, et al. Penicillinbound polyacrylate nanoparticles: restoring the activity of beta-lactam antibiotics against MRSA. Bioorg Med Chem Lett 2007; 17: 3468-3472.
5. Brayner R, Ferrari-Iliou R, Brivois N, et al. Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium. Nano Lett 2006; 6: 866-870.
6. Shahid M, Khan HM, Mustafa S, Shujatullah F. Nanotechnology: implication of nanoparticles in medical science, in emerging trend in Biotechnology' edited by sayyed R Z, I.K International publisher New Dehli, India 2008.
7. Sawai J, Igarashi H, Hashimoto A., Kokugan T, Shimizu M. Evalution of growth inhibitory effect of ceramics powder slurry on bacteria by conductance method. J Chem Eng Japan 1995; 28: 288-293.
8. Stoimenov PK, Klinger R, Marchin GL, Klabunde KJ. 'Metal Oxide Nanoparticles as Bactericidal Agents', Langmuir 2002; 18: 6679-6686.
9. Barry AL, Thronsberry C. Susceptibility test; Diffusion test Procedures, in; The manual of clinical Microbilogy. 5th ed, Editors, Balows A, Hausler Jr. Wj, Hermann KL. Washington: American Society for Microbiology 1991; 1117-1125.
10. Ensor VM, Shahid M, Evans JT, Hawkey PM. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals. J Antimicrob Chemother 2006; 58: 1260-1263.
11. Woodford N, Ward ME, Kaufmann ME, et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum betalactamases in the UK. J Antimicrob Chemother 2004; 54: 735-743.
12. Lingling Zhang, Yunhong Jiang, Yulong Ding, Malcolm Povey, and David W York (2007) Investigation into the antibacterial behaviour of suspensions of ZnO nanoparticles (ZnO nanofluids). Journal of Nanoparticle Research 2007; 9: 479-489.